Zurueck zur Suche

Reporte zur Charge UJ904AC

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
2Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
MI 2 IN 2 WI 2 IL 2 OH 1 NY 1 CA 1 VA 1 MN 1 WV 1 PA 1

VAERS 2602274

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

moderat
Staat
MI
Alter
76,0
Geschlecht
M
Eingang
23.03.2023
Impfdatum
26.09.2022
Beginn
11.03.2023
Tage bis Beginn
166,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Chest X-ray abnormal Dyspnoea Echocardiogram abnormal Ejection fraction normal Electrocardiogram normal Hypoxia Influenza Influenza B virus test positive Left ventricular hypertrophy Lung disorder Myocardial ischaemia Pneumonia SARS-CoV-2 test positive Troponin increased

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/11/2023 Discharge Date: March 14th 2023 PRESENTING PROBLEM: Hypoxemia [R09.02] Influenza B [J10.1] Pneumonia of both lower lobes due to infectious organism [J18.9] COVID-19 [U07.1] HOSPITAL COURSE: 76-year-old man with heart failure preserved ejection fraction, EF 60% persistent atrial fibrillation, status post TAVR, presented to the hospital with shortness of breath on 3/11/2023. COVID-19/influenza B positive. The patient was admitted to the medical service. He did not require supplemental oxygen to maintain normal oxygen saturations. Chest x-ray significant for patchy bibasilar airspace disease and status post TAVR. Dexamethasone/remdesivir were not given as patient was on RA. The patient had increasing troponin 119 -> 157 -> 189, but without chest pain or electrocardiographic changes for acute coronary syndrome. Cardiology was consulted. They stated that it was likely demand ischemia due to COVID-19/influenza. Tamiflu and home medications were resumed as appropriate. Due to concern for possible myocarditis, a TTE was obtained on 3/13/2023. Echocardiogram revealed EF 63 % with mild concentric left ventricular hypertrophy No pericardial effusion appreciated on echocardiogram. Patient has remained on RA and vitals have been stable throughout admission. Patient is asymptomatic this morning with increased tolerance to physical therapy. At this time, recommend patient follow up with primary care provider and cardiologist at discharge. Will arrange for outpatient stress testing. He is currently medically stable for discharge. Plan of care discussed with the patient who is agreeable to the plan of care. Questions answered to his satisfaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
CAD (coronary artery disease) S/P TAVR (transcatheter aortic valve replacement) Persistent atrial fibrillation (HCC) OSA (obstructive sleep apnea) DM type 2 (diabetes mellitus, type 2) (HCC) HTN (hypertension) Arthritis COVID-19 Influenza B Pneumonia due to COVID-19 virus Hypoxemia Myocardial injury Chronic heart failure with preserved ejection fraction (HCC) Transaminitis Abdominal pain Acquired hallux rigidus Acute on chronic diastolic heart failure (HCC) Adrenal nodule (HCC) Anemia CHF (congestive heart failure) (HCC) Choledocholithiasis Cholelithiasis Chorioretinal scar of right eye Diabetic peripheral neuropathy associated with type 2 diabetes mellitus (HCC) Dizziness Dyspnea and respiratory abnormality Epigastric abdominal tenderness Epiretinal membrane (ERM) of left eye Posterior vitreous detachment Primary localized osteoarthrosis of ankle and foot Pulmonary nodule Severe aortic valve stenosis SIRS (systemic inflammatory response syndrome) (HCC) Stable branch retinal vein occlusion of right eye Sepsis (HCC) Morbid obesity (HCC)
Andere Medikamente
allopurinol (ZYLOPRIM) 300 MG tablet amLODIPine (NORVASC) 10 MG tablet atorvastatin (LIPITOR) 40 MG tablet cpap cyanocobalamin 1000 MCG tablet ezetimibe (ZETIA) 10 MG tablet ferrous sulfate 325 (65 Fe) MG delayed release tablet furosemide (
Allergien
Hmg-coa-r InhibitorsMyalgia, Unknown SimvastatinMyalgia
Vorherige Impfungen
-

VAERS 2453632

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

moderat
Staat
OH
Alter
76,0
Geschlecht
M
Eingang
21.09.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Chills Fall Fatigue Feeling cold Headache Neck pain Palpitations Tremor

Symptomtext

Patient called pharmacy 09/21/22 detailing reaction. First felt "excruciating pain" in lower back after leaving pharmacy, pain traveling up the lower back and towards the head/neck area. Patient stated pounding heartbeat, and carotid artery visibly pulsating in neck. Patient states pain was overwhelming enough they fell out of their car when arriving home. Then felt cold and chills, trembling/shaking vigorously for approximately 1 hour, which then resolved. Throughout this process patient called local ER, but did not go to emergency room. Only lingering side effects include excessive tiredness. Pharmacist advised patient to follow up with primary care physician, and if symptoms worsen to seek emergency care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None known.
Vorgeschichte
None known, patient stated 09/21/22 history of fatty liver.
Andere Medikamente
Fluzone HD vaccine 09/20/22.
Allergien
NKA
Vorherige Impfungen
-

VAERS 2450657

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ac

moderat
Staat
NY
Alter
76,0
Geschlecht
F
Eingang
18.09.2022
Impfdatum
18.09.2022
Beginn
18.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Pulse absent

Symptomtext

Patient experienced difficulty breathing and had no detectable pulse within 5 minutes after receiving both immunizations. Epinephrine 0.3mg was administered, dose was repeated 2 additional times every 5 minutes until paramedic arrived. Patient did not lose consciousness. Patient was given oxygen and transported to hospital for evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2446619

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

moderat
Staat
CA
Alter
81,0
Geschlecht
F
Eingang
15.09.2022
Impfdatum
13.09.2022
Beginn
13.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Chills Decreased appetite Feeling abnormal Pain Tremor

Symptomtext

Felt awful. Every but of me hurt. I got very Shakey. Chills. No appetite. Weak, No treatment. Felt better in 36 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No, none.
Vorgeschichte
Asthma , but controlled and I have never had a reaction to a vaccination before. This was just a flu shot. I was pretty sick for 36 hrs.
Andere Medikamente
Pravastatin, Zetia, Pulmicort, Albuterol., multivitamin
Allergien
Allergic to sulfa drugs.
Vorherige Impfungen
-

VAERS 2512497

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ac

mild
Staat
IN
Alter
78,0
Geschlecht
M
Eingang
20.11.2022
Impfdatum
17.10.2022
Beginn
15.11.2022
Tage bis Beginn
29,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain lower Alanine aminotransferase normal Anion gap Anticoagulant therapy Aspartate aminotransferase normal Asthenia Bacterial test positive Basophil count normal Basophil percentage decreased Bilirubin urine present Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood lactic acid

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: on November 15, 2022 04:58 Verified By: on November 15, 2022 04:58 Encounter Info: Inpatient, 11/15/22 - * Final Report * Chief Complaint vomiting History of Present Illness/Subjective 78 year old male s/p right inguinal hernia repair on 10/3/22, presented complaining of abd pain and generalized weakness. Pt endorses diffuse lower abdominal pain w/ associated generalized weakness, nausea, and 3-4 episodes of emesis for the past several hours today. Last BM 6 hrs ago. He denies fevers, chest pain, dyspnea, cough, or other complaints. Pt has hx of SBO in July, treated with conservative management and his last BM was today. Has not passed gas since last bowel movement. In the ED, the provider made multiple attempts to place an NG tube which were unsuccessful and resulted in some mild epistaxis which is since resolved, patient is requesting no additional attempts be made at this time for placement of the NG tube understanding that there is a risk of further obstruction and complications the longer we wait to decompress the stomach including possible aspiration of stomach contents and patient is experiencing vomiting since arriving to the floor however he understands he is concerns and still would like to delay additional attempts to place an NG tube for the time being and and rest in the interim. As per the ED provider, the Surgeon on call was requested to consult on the patient while in the ED, he agreed to see the patient in the am and recommended admission to medicine in the interim. I spent greater than 50 minutes in the evaluation and management of this patient with more than 50% of the time spent counseling and/or coordinating care. I counseled the patient and/or family about the findings, differential diagnoses, my assessment, recommendations, and plan. I coordinated care with the multidisciplinary healthcare team. Review of Systems A complete, 13-system review was performed and was negative except for as noted in the HPI. Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) Temp (CEL) 36.7 (36.7-36.7) Temp (FAHR) 98.1 (98.1-98.1), BP 146/72 (146-146)/(72-72), HR 83 (82-87), RR 22 (20-22), O2Sat 99 (97-99) Patient Weight Current Daily Weight: 80.7 kg 11/15/22 BMI: 25.7 11/15/22 Overweight (BMI 25-29.9) Patient Height Current Height: 177.3 cm 11/15/22 Constitutional: No acute distress, well-nourished Eyes: PERRL, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, distended, absent bowel sounds Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. SBO (small bowel obstruction) K56.609 2. Hx of hernia repair Z98.890 General surgery consult would be appreciated As above patient is temporarily refusing NG tube, will maintain elevation of bed 30 degrees or greater in the interim QTC is borderline will need to monitor it with frequent EKGs in between doses of Zofran and discontinue use if lengthening Pain control with as little opioid therapy as possible to superimposed ileus Strict n.p.o., continue IV fluid, serial exams, trend lactate, trend CBC and electrolytes continue Rocephin Flagyl 3. High cholesterol E78.00 4. Hypertension I10 5. S/P AVR (aortic valve replacement) Z95.2 Noted continue home medications as appropriate 6. COPD without exacerbation J44.9 resp eval, cont home meds as appropriate Orders: fluticasone-vilanterol, 1 Puff, Inhalation, Aerosol Powder, MDI/DPI Inhaler Treatment, Daily, 11/15/22 9:00:00 heparin, 5,000 Units, Subcutaneous, Injection, Q8H, Routine, 11/15/22 3:00:00 HYDROmorphone, 0.5 mg, IV Push, Injection, Q4H, PRN, Pain Severe IV (7-10 out of 10), 11/15/22 2:05:00 Lactated Ringers 1,000 mL, Total Volume (mL) = 1,000, IV, 11/15/22 2:05:00, 75 mL/hr, Clinical Weight morphine, 2 mg, IV Push, Injection, Q4H, PRN, Pain Moderate IV (4-6 out of 10), 11/15/22 2:05:00 umeclidinium, 1 Puff, Inhalation, Aerosol Powder, MDI/DPI Inhaler Treatment, Daily, 11/15/22 9:00:00 Admit to Inpatient Auto Diff Call Blood Glucose Call Diastolic Blood Pressure Call Heart Rate Call Mental Status Changes Call O2 Saturation Call Respiratory Distress Call Respiratory Rate Call Systolic Blood Pressure Call Temperature Call Urine Output CBC w/Differential Comp Metabolic Panel Electrocardiogram Fall Precautions Gluc-Strip POC Initiate IV Care Protocols As Appropriate Initiate Mobility Protocol Initiate Protocol Initiate Skin and Wound Care Protocol Intake + Output Strict Lactate Pl Venous QN Level of Care Magnesium SerPl QN Medical Service Nasogastric Tube Nasogastric Tube Output Nasogastric Tube Output NPO OT Evaluation and Treatment Phosphorus SerPl QN PT Evaluation and Treatment Resp Evaluation or Assessment Resuscitation Status Sequential Compression Device Single Oxygen Saturation Telemetry Class III 24hr Recommendation Vital Signs Weight Weight Patient is DNR/DNI Code Status Resuscitation Status - Ordered -- 11/15/22 2:05:00, DNR/DNI/Comprehensive Care Chronic Problem List Dilated cardiomyopathy High cholesterol Hypertension Inguinal hernia of right side without obstruction or gangrene S/P AVR (aortic valve replacement) S/P placement of cardiac pacemaker Procedure/Surgical History ?Excision of left shoulder cyst (07/01/2020) ?Excision of left temporal cyst (07/01/2020) ?PPM implantation (01/18/2018) ?cardioversion (11/06/2017) ?AVR & Maze Procedure (05/09/2017) ?Tonsillectomy (1948) ?Cardiac catheterisation ?Cataracts, bilateral ?cyst removed from back ?Robot AsstLaparoscopic Right Inguinal Hernia Repair possible Left Surgical History Internal 10/03/2022 Hernia Repair Inguinal 05/09/2017 Aortic Valve Replacement Medications Home Medications (10) Active amiodarone 100 mg oral tablet 100 mg = 1 Tablet, Orally, QAM amLODIPine 5 mg oral tablet 5 mg = 1 Tablet, Orally, QAM aspirin 81 mg oral tablet 81 mg, Orally, Daily carvedilol 25 mg oral tablet 25 mg = 1 Tablet, Orally, BID Colace 100 mg oral capsule 100 mg = 1 Capsule, PRN, Orally, BID furosemide 20 mg oral tablet 20 mg = 1 Tablet, Orally, QAM Spiriva 18 mcg inhalation capsule 18 mCg = 1 Capsule, Inhalation, QAM Vitamin B12 1000 mCg oral tablet 1,000 mCg = 1 Tablet, Orally, QAM Vitamin C 1000 mg oral tablet 1,000 mg = 1 Tablet, Orally, QAM Wixela Inhub 250 mCg-50 mCg inhalation powder 1 Puff, Inhalation, BID Active Scheduled Inpatient Medications fluticasone-vilanterol (Breo Ellipta 200 mCg-25 mCg inhalation powder), Aerosol Powder, 1 Puff, Inhalation, Daily, Start: 11/15/22 09:00:00 heparin (heparin 5,000 units/0.5 mL injectable solution), Injection, 5,000 Units, Subcutaneous, Q8H, Start: 11/15/22 03:00:00 umeclidinium (Incruse Ellipta 62.5 mCg inhalation powder), Aerosol Powder, 1 Puff, Inhalation, Daily, Start: 11/15/22 09:00:00 Lactated Ringers 1,000 mL IV 75 mL/hr One-Time Medications Given 11/14/22 00:00:00 TO 11/15/22 04:58:32 ondansetron (Zofran), Injection, 4 mg, IV Push, ONCE, (1 DOSE 11/15/22 02:47:00) PRN Medications (0600 - 0559) from 11/14 - 11/15 HYDROmorphone, 0.5 mg, IV Push, Q4H, 1 Dose(s) morphine, 2 mg, IV Push, Q4H, 0 Dose(s) Allergies lisinopril (facial swelling) Social History Alcohol Current, Beer, 1-2 times per week Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment Lives with Spouse. Living situation: Home/Independent. Nutrition/Health Diet: Regular. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Arthritis: Mother. Cancer: Father. Heart disease: Mother. Liver cancer..: Father. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 17 k/cumm High (11/15/22 02:12:00) RBC: 5.09 million/cumm (11/15/22 02:12:00) Hgb: 14.3 GM/dL (11/15/22 02:12:00) Hct: 42.8 % (11/15/22 02:12:00) MCV: 84 fL (11/15/22 02:12:00) MCH: 28.1 pg (11/15/22 02:12:00) MCHC: 33.3 GM/dL (11/15/22 02:12:00) RDW: 17.2 % High (11/15/22 02:12:00) Platelet: 265 k/cumm (11/15/22 02:12:00) MPV: 8.9 fL (11/15/22 02:12:00) Neutrophils %: 92 % (11/15/22 02:12:00) Lymphocytes %: 2 % (11/15/22 02:12:00) Monocytes %: 6 % (11/15/22 02:12:00) Eosinophils %: 0 % (11/15/22 02:12:00) Basophils %: 0 % (11/15/22 02:12:00) Absolute Neutrophil: 15.5 k/cumm High (11/15/22 02:12:00) Absolute Lymphocyte: 0.3 k/cumm Low (11/15/22 02:12:00) Absolute Monocyte: 1 k/cumm (11/15/22 02:12:00) Absolute Eosinophil: 0 k/cumm (11/15/22 02:12:00) Absolute Basophil: 0.1 k/cumm (11/15/22 02:12:00) Chemistry: Sodium SerPl QN: 141 mmol/L (11/15/22 02:12:00) Potassium SerPl QN: 4.3 mmol/L (11/15/22 02:12:00) Chloride SerPl QN: 100 mmol/L (11/15/22 02:12:00) Carbon Dioxide SerPl QN: 23 mmol/L (11/15/22 02:12:00) Anion Gap: 18 mmol/L High (11/15/22 02:12:00) BUN SerPl QN: 25 mg/dL High (11/15/22 02:12:00) Creatinine SerPl QN: 1.21 mg/dL (11/15/22 02:12:00) Estimated GFR (CKD-EPI, no race): 61 mL/min/1.73m2 (11/15/22 02:12:00) Estimated CRCL (CG): 54 mL/min Low (11/15/22 02:12:00) Glucose SerPl QN: 144 mg/dL High (11/15/22 02:12:00) Calcium Total SerPl QN: 9.7 mg/dL (11/15/22 02:12:00) Phosphorus SerPl QN: 3.3 mg/dL (11/15/22 02:12:00) Alkaline Phos SerPl QN: 80 Units/L (11/15/22 02:12:00) ALT SerPl QN: 9 Units/L (11/15/22 02:12:00) AST SerPl QN: 14 Units/L (11/15/22 02:12:00) Bilirubin Total SerPl QN: 0.8 mg/dL (11/15/22 02:12:00) Total Protein SerPl QN: 7.5 GM/dL (11/15/22 02:12:00) Albumin SerPl QN: 4.4 GM/dL (11/15/22 02:12:00) Magnesium SerPl QN: 2 mg/dL (11/15/22 02:12:00) Troponin-I High Sensitivity: 9 ng/L (11/14/22 21:50:00) Lactate Venous Pl QN: 1 mmol/L (11/15/22 02:12:00) Gluc-Strip, POC: 155 mg/dL High (11/15/22 02:49:00) Coagulation: PT: 12.1 seconds (11/14/22 21:50:00) INR: 1.06 (11/14/22 21:50:00) Urine Studies: Color: Yellow (11/14/22 23:53:00) Clarity: Clear (11/14/22 23:53:00) Specific Gravity: 1.020 (11/14/22 23:53:00) pH: 5.5 (11/14/22 23:53:00) Protein: TRACE. Abnormal (11/14/22 23:53:00) Glucose: NEGATIVE (11/14/22 23:53:00) Ketones: TRACE. Abnormal (11/14/22 23:53:00) Bilirubin: SC Small Abnormal (11/14/22 23:53:00) Hgb Ur: NEGATIVE (11/14/22 23:53:00) Nitrite: NEGATIVE (11/14/22 23:53:00) Urobilinogen: 1.0. (11/14/22 23:53:00) Leukocyte Esterase Ur: NEGATIVE (11/14/22 23:53:00) WBC: 6-10 Abnormal (11/14/22 23:53:00) RBC: 3-5 Abnormal (11/14/22 23:53:00) Bacteria: TRACE. (11/14/22 23:53:00) Squamous Epithelial: Few (11/14/22 23:53:00) Mucous: PRESENT. (11/14/22 23:53:00) Hyaline Casts: 3-5 (11/14/22 23:53:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (11/14/22 23:47:00) Coronavirus SARS-CoV2 Rapid: Not Detected (11/14/22 23:47:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/14/2022 23:09 - CT Abd/Pelvis W/IV Contrast IMPRESSION:1. Findings concerning for recurrent high-grade small bowelobstruction.Results were communicated and receipt was documented in the System.Thank you for consulting our team of subspecialty radiologists. Signature Line Electronically Signed on 11/15/22 04:58 ________________________________________________________

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain lower
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493457

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj904ac

mild
Staat
WI
Alter
67,0
Geschlecht
F
Eingang
29.10.2022
Impfdatum
25.10.2022
Beginn
29.10.2022
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site warmth

Symptomtext

patient called claiming that after the initial injection the reaction from the vaccine caused the area to look red and feel warm to the touch. she stated that the area around the injection site is improving but the area has now moved to another location where it is red and tender. My thoughts that I said were a potential bacterial/cellulitis infection. I recommended going into urgent care and getting the area looked at due to the description the patient gave. The patient stated they would probably go into urgent care tomorrow from my suggestion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none known at this time.
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
levothyroxine 125 mcg, metformin, lisinopril, rosuvastatin,
Allergien
no known allergies listed
Vorherige Impfungen
-

VAERS 2491292

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
MI
Alter
65,0
Geschlecht
F
Eingang
27.10.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site pain Nausea

Symptomtext

Patient appears with redness underneath injection site and tender to the touch. Size of redness is about 6-7 inches in diameter. Patient also states she experiences nausea. It has been 2 days since injection and redness is still there. Patient states that this has happened last year as well when she got her Fluzone HD. She had never had any reaction when she got the Fluzone Quadrivalent.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
Fluzone HD quadrivalent

VAERS 2489922

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
VA
Alter
68,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
24.10.2022
Beginn
26.10.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site rash Injection site warmth

Symptomtext

RED/WARM RASH BELOW INJECTION SITE APPEARED 10/26

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
NON LISTED ON PHARMACY PROFILE
Allergien
NO KNOWN ALLERGIES
Vorherige Impfungen
-

VAERS 2484824

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
MN
Alter
66,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
17.10.2022
Beginn
18.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Musculoskeletal stiffness Neck pain

Symptomtext

Patient had Fluzone HD, Prevnar 20 and Pfizer bivalent booster on Monday 10/17/2022. Patient called the pharmacy today Thursday 10/20/22 and complains of neck pain. The neck pain is mostly in the back and stiffness up towards base of skull. Neck pain started Tuesday late morning. No fever, no issues at injection site, has full range of motion, can move chin to chest, no other symptoms per patient. Also, stated there was no injection site swelling or redness and barely any pain. Patient is at urgent care now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Multiple Sclerosis
Andere Medikamente
VITAMIN D, CALCIUM, PRESERVISION, PIOGLITAZONE/METFORMIN, LEVOTHYROXINE, ROSUVASTATIN,
Allergien
NONE
Vorherige Impfungen
-

VAERS 2480532

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
IL
Alter
73,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
06.10.2022
Beginn
08.10.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Musculoskeletal stiffness Pain Pruritus Swelling Urticaria

Symptomtext

She got her vaccine, there was nothing that day or the next day. On the 2nd day it started itching, and that was not a big deal as she has had that before. Then it started wheeling up, the next day when she would rub on it to get the itching gone it would be very painful. This lasted for about 8 days. She has a little bit of soreness, a little lump, some itching and stiffness in her arm in the last couple of days. She has not had any reactions to any other vaccines prior. She took some Tylenol a night or not, but does she does take some allergy pills. She called the pharmacist and he told her to call the CDC and they gave her our phone #. She is concerned that one of her cousins had such a bad reaction that it caused an autoimmune problem and was in the hospital and a nursing home over a year and he said for her to tell her blood relatives not to take the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None.
Vorgeschichte
Diabetes, high blood pressure, high cholesterol, pulmonary embolism (November 2020), gout.
Andere Medikamente
Lantus insulin, Humalog, AREDS II (generic), Glimepiride, Atorvastatin, Biotin, zinc, Vitamin B6, hydrochlorothiazide, Lisinopril, Atenolol, Xarelto, Uloric.
Allergien
Penicillin, sulfa.
Vorherige Impfungen
-

VAERS 2475487

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
WV
Alter
78,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
07.10.2022
Beginn
10.10.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site swelling Injection site urticaria Injection site vesicles Urticaria

Symptomtext

A patient got the flu vaccine on 10/07 and a couple days later developed a large welt below the injection site. She said it had some blisters too. She came the next day and I looked at it and it was swollen and red but no blisters. It seemed to be below the injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475478

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
-
Alter
69,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
08.10.2022
Beginn
09.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site warmth Peripheral swelling

Symptomtext

The patient got the vaccine on 10/08/22. By 10/09/22 the patient arm began to swell. She had a localized reaction that was red and warm to touch. It seemed to be below injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2462065

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
WI
Alter
84,0
Geschlecht
F
Eingang
27.09.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site irritation Pain in extremity

Symptomtext

Pt came in today and said that she received the flu shot and her covid 19 bivalent booster on 9/23/22 and that the arm that she got her flu shot in really hurt. She said that the vaccine hurt when she received the shot and she had a quarter sized bruise in the location (left arm) today (9/27/22). She also indicated that her arm was still hurting and upon observation the skin on her upper arm looked very red and irritated. I let her know that it might be infected and that she should contact her dr. I also called the patient's primary physician and let them know that her arm looked infected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2459995

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
PA
Alter
81,0
Geschlecht
F
Eingang
25.09.2022
Impfdatum
15.09.2022
Beginn
16.09.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Malaise Respiratory tract congestion Rhinorrhoea

Symptomtext

PT said as of 9/25/22 she felt ill after her Fluzone HD administered 09/15/22. She thought this may be due to the "NEW" senior flu shot that was out. I informed the pt that Fluzone HD, while periodically reformulated, has been out for years, and that we had administered Fluzone HD to the pt for several years. Pt stated she felt "sick", coughing, runny nose, congestion. Suggested that the patient call her PCP for further guidance as the symptoms have been going on for 10 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
METOPROLOL, PANTOPRAZOLE, DULOXETINE, ATORVASTATIN, MELOXICAM
Allergien
ERYTHROMYCIN(RASH), SULFA ANTIBIOTICS(RASH)
Vorherige Impfungen
-

VAERS 2456722

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ904AC

mild
Staat
IL
Alter
81,0
Geschlecht
M
Eingang
23.09.2022
Impfdatum
21.09.2022
Beginn
23.09.2022
Tage bis Beginn
2,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Patient came in today stating that he received a flu shot a few days ago and has had a red and swollen arm with the swelling and redness spreading down to his elbow, the symptoms started yesterday. He pointed to a spot on his arm that he states he received the vaccination in. It seemed a little lower than usual (but seemed to be near the tail end of the deltoid muscle). I advised him to take a picture of the swollen arm and send it to his MD. I advised him to apply hydrocortisone and ice as needed and to take tylenol for pain as he can not take NSAIDS due to other meds. I told him I would check in on him in the evening. I spoke with the administering Pharmacist who stated she always gives in the upper arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Not known
Vorgeschichte
Patient has cardiac health problems and is on warfarin and other antiarryhthmic medications
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2444785

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge Uj904AC

mild
Staat
IN
Alter
74,0
Geschlecht
F
Eingang
14.09.2022
Impfdatum
14.09.2022
Beginn
14.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Haemorrhage Injection site discolouration Injection site nodule

Symptomtext

Patient states that the vaccine bandage was full of blood to the point of overflowing. She stated that there was also a bluish knot at the injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discolouration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-